Oleander attenuates hepatic inflammation in a TLR4-independent manner and by favorable modulation of hepatocellular global metabolome that supports cytoprotection

J Ethnopharmacol. 2024 Apr 6:323:117717. doi: 10.1016/j.jep.2024.117717. Epub 2024 Jan 3.

Abstract

Ethnopharmacological relevance: Nerium oleander is used to treat liver-associated chronic metabolic diseases in traditional medicinal systems across the globe. The hepatoprotective effects of oleander are mentioned in Indian and Chinese traditional medicinal literature.

Aim of the study: The present study aimed to investigate the cellular mechanisms behind the hepatoprotective effects of a non-toxic dose of oleander (NO).

Materials and methods: The hepatoprotective effects of NO were tested against lipopolysaccharide (LPS)-treated HepG2 cells. Oxidative stress response was studied using cellular enzymatic assays, and gene expression was analyzed using qRT-PCR. HepG2 cells were pretreated with TAK-242 (pharmacological inhibitor of TLR4) to decipher the anti-inflammatory mechanisms of NO. Cell-free metabolites were analyzed using GCMS and were subjected to pathway enrichment analysis.

Results: NO reduced systemic inflammation, serum lipid peroxidation byproducts, and glucose without affecting serum transaminase levels and hepatic histopathological features. NO attenuated the inflammation-induced loss of antioxidant enzyme activities and mRNA expressions of toll-like receptor-4 (TLR4)/nuclear factor κβ (NFκβ)-dependent inflammatory genes. In TAK-242 pretreated cells, LPS was unable to induce inflammatory and oxidative responses. However, NO treatment in TAK-242 pretreated cells with LPS stimulation further reduced the signs of inflammation and improved hepatoprotective activities. A comparative analysis of the intracellular global metabolome from HepG2 cells with and without NO treatment indicated NO-mediated favorable modulation of intracellular metabolic pathways that support cytoprotective activities.

Conclusion: NO protects HepG2 cells from LPS-induced oxidative and inflammatory injury. The hepatoprotective effects of NO are mediated by a TLR4-independent process and through a favorable modulation of the intracellular global metabolome that supports cytoprotection.

Keywords: Antioxidant; Cytoprotection; Diabetes; Inflammation; Metabolome; Nerium oleander; TLR4.

MeSH terms

  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Carcinoma, Hepatocellular*
  • Cytoprotection
  • Humans
  • Inflammation / chemically induced
  • Inflammation / drug therapy
  • Lipopolysaccharides / metabolism
  • Lipopolysaccharides / toxicity
  • Liver Neoplasms*
  • Metabolome
  • Nerium*
  • Sulfonamides*
  • Toll-Like Receptor 4 / genetics
  • Toll-Like Receptor 4 / metabolism

Substances

  • ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate
  • Lipopolysaccharides
  • Toll-Like Receptor 4
  • Antioxidants
  • TLR4 protein, human
  • Sulfonamides